Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Differences in cognitive function due to acute sedative effects of risperidone and quetiapine in stable bipolar I outpatients

Trial Profile

Differences in cognitive function due to acute sedative effects of risperidone and quetiapine in stable bipolar I outpatients

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Mar 2010

At a glance

  • Drugs Quetiapine; Risperidone
  • Indications Bipolar I disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top